Lei Nie

3.5k total citations · 1 hit paper
72 papers, 2.0k citations indexed

About

Lei Nie is a scholar working on Statistics and Probability, Management Science and Operations Research and Economics and Econometrics. According to data from OpenAlex, Lei Nie has authored 72 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Statistics and Probability, 11 papers in Management Science and Operations Research and 9 papers in Economics and Econometrics. Recurrent topics in Lei Nie's work include Statistical Methods in Clinical Trials (42 papers), Advanced Causal Inference Techniques (20 papers) and Statistical Methods and Bayesian Inference (20 papers). Lei Nie is often cited by papers focused on Statistical Methods in Clinical Trials (42 papers), Advanced Causal Inference Techniques (20 papers) and Statistical Methods and Bayesian Inference (20 papers). Lei Nie collaborates with scholars based in United States, China and Netherlands. Lei Nie's co-authors include Richard Pazdur, Ann T. Farrell, Haitao Chu, Donna Przepiorka, Stacy S. Shord, Bahru Habtemariam, Robert Q. Le, Liang Li, Weishi Yuan and Ying Yuan and has published in prestigious journals such as Journal of the American Statistical Association, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Lei Nie

66 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell-Induced Severe or Life-Threatening Cytokine Release Syndrome

2018 610 citations Robert Q. Le, Liang Li et al. The Oncologist profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lei Nie United States	22	659	545	304	257	221	72	2.0k
Myron Chang United States	33	467 0.7×	722 1.3×	236 0.8×	70 0.3×	883 4.0×	126	3.4k
Pascal Girard France	27	437 0.7×	602 1.1×	145 0.5×	75 0.3×	133 0.6×	102	2.3k
Brian P. Hobbs United States	35	1.1k 1.7×	1.4k 2.6×	234 0.8×	49 0.2×	86 0.4×	149	4.9k
Mei‐Jie Zhang United States	28	449 0.7×	454 0.8×	184 0.6×	59 0.2×	674 3.0×	112	2.5k
Mark D. Rothmann United States	16	382 0.6×	443 0.8×	135 0.4×	29 0.1×	508 2.3×	46	1.9k
Dirk F. Moore United States	34	338 0.5×	769 1.4×	100 0.3×	130 0.5×	46 0.2×	120	3.5k
John O’Quigley France	37	2.9k 4.5×	768 1.4×	437 1.4×	47 0.2×	518 2.3×	133	5.3k
Pavlos Msaouel United States	31	138 0.2×	1.1k 2.0×	237 0.8×	158 0.6×	57 0.3×	225	3.4k
Anthony Rossini United States	21	582 0.9×	52 0.1×	96 0.3×	287 1.1×	140 0.6×	42	1.8k
Joseph S. Koopmeiners United States	28	305 0.5×	273 0.5×	83 0.3×	71 0.3×	21 0.1×	109	2.2k

Countries citing papers authored by Lei Nie

Since Specialization

Citations

This map shows the geographic impact of Lei Nie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Nie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Nie more than expected).

Fields of papers citing papers by Lei Nie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lei Nie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Nie. The network helps show where Lei Nie may publish in the future.

Co-authorship network of co-authors of Lei Nie

This figure shows the co-authorship network connecting the top 25 collaborators of Lei Nie. A scholar is included among the top collaborators of Lei Nie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lei Nie. Lei Nie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gruber, Susan, Haitao Chu, Shiowjen Lee, et al.. (2025). Use of Real‐World Data and Real‐World Evidence in Rare Disease Drug Development: A Statistical Perspective. Clinical Pharmacology & Therapeutics. 117(4). 946–960. 2 indexed citations

Nie, Lei, Shiowjen Lee, Haitao Chu, et al.. (2025). Challenges and Possible Strategies to Address Them in Rare Disease Drug Development: A Statistical Perspective. Clinical Pharmacology & Therapeutics. 118(1). 62–73. 1 indexed citations

Nie, Lei, et al.. (2025). The research on the infrared time-sequence imaging inspection method for internal defects of 3D TSV packaging. Microelectronics Reliability. 166. 115608–115608.

Gilbert, Peter B., James Peng, Larry Han, et al.. (2024). A surrogate endpoint-based provisional approval causal roadmap, illustrated by vaccine development. Biostatistics. 26(1).

Zhou, Heng, et al.. (2024). Robustness Assessment of Oncology Dose-Finding Trials Using the Modified Fragility Index. Cancers. 16(20). 3504–3504. 1 indexed citations

Zhang, Zhiwei, Zonghui Hu, Dean Follmann, & Lei Nie. (2023). Estimating the average treatment effect in randomized clinical trials with all-or-none compliance. The Annals of Applied Statistics. 17(1).

Peng, Yang, et al.. (2023). SAM: Self-Adapting Mixture Prior to Dynamically Borrow Information from Historical Data in Clinical Trials. Biometrics. 79(4). 2857–2868. 9 indexed citations

Liu, Jialing, et al.. (2023). Borrowing Concurrent Information from Non-Concurrent Control to Enhance Statistical Efficiency in Platform Trials. Current Oncology. 30(4). 3964–3973. 3 indexed citations

Jiang, Liyun, Lei Nie, & Ying Yuan. (2021). Elastic priors to dynamically borrow information from historical data in clinical trials. Biometrics. 79(1). 49–60. 27 indexed citations

10.

Kasamon, Yvette L., Haiyan Chen, R. Angelo de Claro, et al.. (2019). FDA Approval Summary: Mogamulizumab-kpkc for Mycosis Fungoides and Sézary Syndrome. Clinical Cancer Research. 25(24). 7275–7280. 51 indexed citations

11.

Przepiorka, Donna, Lola Luo, Sriram Subramaniam, et al.. (2019). FDA Approval Summary: Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease. The Oncologist. 25(2). e328–e334. 91 indexed citations

12.

Le, Robert Q., Liang Li, Weishi Yuan, et al.. (2018). FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell-Induced Severe or Life-Threatening Cytokine Release Syndrome. The Oncologist. 23(8). 943–947. 610 indexed citations breakdown →

13.

Zhou, Heng, Ying Yuan, & Lei Nie. (2018). Accuracy, Safety, and Reliability of Novel Phase I Trial Designs. Clinical Cancer Research. 24(18). 4357–4364. 72 indexed citations

14.

Yuan, Ying, Ruitao Lin, Daniel Li, Lei Nie, & Katherine E. Warren. (2018). Time-to-Event Bayesian Optimal Interval Design to Accelerate Phase I Trials. Clinical Cancer Research. 24(20). 4921–4930. 84 indexed citations

15.

Pulte, Dianne, Jonathon Vallejo, Donna Przepiorka, et al.. (2018). FDA Supplemental Approval: Blinatumomab for Treatment of Relapsed and Refractory Precursor B-Cell Acute Lymphoblastic Leukemia. The Oncologist. 23(11). 1366–1371. 44 indexed citations

16.

Zhang, Zhiwei, Shujie Ma, Lei Nie, & Guoxing Soon. (2017). A Quantitative Concordance Measure for Comparing and Combining Treatment Selection Markers. The International Journal of Biostatistics. 13(1). 1 indexed citations

17.

Carlin, Bradley P., James D. Neaton, Guoxing Soon, et al.. (2013). Network meta-analysis of randomized clinical trials: Reporting the proper summaries. Clinical Trials. 11(2). 246–262. 89 indexed citations

18.

Nie, Lei, et al.. (2013). Study on Mineral Distribution of Peat Soil in Northeast China. Asian Journal of Chemistry. 25(18). 10150–10152. 1 indexed citations

19.

Nie, Lei & Guoxing Soon. (2010). A covariate‐adjustment regression model approach to noninferiority margin definition. Statistics in Medicine. 29(10). 1107–1113. 12 indexed citations

20.

Li, Runze & Lei Nie. (2007). Efficient Statistical Inference Procedures for Partially Nonlinear Models and their Applications. Biometrics. 64(3). 904–911. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact